113 related articles for article (PubMed ID: 21093273)
1. Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.
Shao L; Wang F; Malcolm SC; Ma J; Hewitt MC; Campbell UC; Bush LR; Spicer NA; Engel SR; Saraswat LD; Hardy LW; Koch P; Schreiber R; Spear KL; Varney MA
Bioorg Med Chem; 2011 Jan; 19(1):663-76. PubMed ID: 21093273
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050.
Shaw AM; Boules M; Zhang Y; Williams K; Robinson J; Carlier PR; Richelson E
Eur J Pharmacol; 2007 Jan; 555(1):30-6. PubMed ID: 17109850
[TBL] [Abstract][Full Text] [Related]
3. 2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.
Carter DS; Cai HY; Lee EK; Iyer PS; Lucas MC; Roetz R; Schoenfeld RC; Weikert RJ
Bioorg Med Chem Lett; 2010 Jul; 20(13):3941-5. PubMed ID: 20570146
[TBL] [Abstract][Full Text] [Related]
4. 6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.
Micheli F; Cavanni P; Andreotti D; Arban R; Benedetti R; Bertani B; Bettati M; Bettelini L; Bonanomi G; Braggio S; Carletti R; Checchia A; Corsi M; Fazzolari E; Fontana S; Marchioro C; Merlo-Pich E; Negri M; Oliosi B; Ratti E; Read KD; Roscic M; Sartori I; Spada S; Tedesco G; Tarsi L; Terreni S; Visentini F; Zocchi A; Zonzini L; Di Fabio R
J Med Chem; 2010 Jul; 53(13):4989-5001. PubMed ID: 20527970
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.
Lee KH; Park CE; Min KH; Shin YJ; Chung CM; Kim HH; Yoon HJ; Won-Kim ; Ryu EJ; Shin YJ; Nam HS; Cho JW; Lee HY
Bioorg Med Chem Lett; 2010 Sep; 20(18):5567-71. PubMed ID: 20724153
[TBL] [Abstract][Full Text] [Related]
6. Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties.
Tian JW; Jiang WL; Zhong Y; Meng Q; Gai Y; Zhu HB; Hou J; Xing Y; Li YX
Neuroscience; 2011 Nov; 196():124-30. PubMed ID: 21925241
[TBL] [Abstract][Full Text] [Related]
7. [Synthesis and antidepressant activities of aryl alkanol piperidine derivatives].
Zheng YY; Gao K; Weng ZJ; Li JQ
Yao Xue Xue Bao; 2010 Mar; 45(3):324-9. PubMed ID: 21351508
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.
Carlier PR; Lo MM; Lo PC; Richelson E; Tatsumi M; Reynolds IJ; Sharma TA
Bioorg Med Chem Lett; 1998 Mar; 8(5):487-92. PubMed ID: 9871604
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo characterization of PA01, a novel promising triple reuptake inhibitor.
Hou J; Xing Y; Zuo D; Wu Y; Tian J; Meng Q; Yang M
Physiol Behav; 2015 Jan; 138():141-9. PubMed ID: 25447484
[TBL] [Abstract][Full Text] [Related]
10. Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.
Shao L; Hewitt MC; Wang F; Malcolm SC; Ma J; Campbell JE; Campbell UC; Engel SR; Spicer NA; Hardy LW; Schreiber R; Spear KL; Varney MA
Bioorg Med Chem Lett; 2011 Mar; 21(5):1438-41. PubMed ID: 21310609
[TBL] [Abstract][Full Text] [Related]
11. The antidepressant-like pharmacological profile of Yuanzhi-1, a novel serotonin, norepinephrine and dopamine reuptake inhibitor.
Jin ZL; Gao N; Li XR; Tang Y; Xiong J; Chen HX; Xue R; Li YF
Eur Neuropsychopharmacol; 2015 Apr; 25(4):544-56. PubMed ID: 25638027
[TBL] [Abstract][Full Text] [Related]
12. The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization properties.
Caldarone BJ; Paterson NE; Zhou J; Brunner D; Kozikowski AP; Westphal KG; Korte-Bouws GA; Prins J; Korte SM; Olivier B; Ghavami A
J Pharmacol Exp Ther; 2010 Dec; 335(3):762-70. PubMed ID: 20864506
[TBL] [Abstract][Full Text] [Related]
13. Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.
Bannwart LM; Carter DS; Cai HY; Choy JC; Greenhouse R; Jaime-Figueroa S; Iyer PS; Lin CJ; Lee EK; Lucas MC; Lynch SM; Madera AM; Moore A; Ozboya K; Raptova L; Roetz R; Schoenfeld RC; Stein KA; Steiner S; Villa M; Weikert RJ; Zhai Y
Bioorg Med Chem Lett; 2008 Dec; 18(23):6062-6. PubMed ID: 18954985
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant-like pharmacological profile of a novel triple reuptake inhibitor, (1S,2S)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS).
Liang Y; Shaw AM; Boules M; Briody S; Robinson J; Oliveros A; Blazar E; Williams K; Zhang Y; Carlier PR; Richelson E
J Pharmacol Exp Ther; 2008 Nov; 327(2):573-83. PubMed ID: 18689611
[TBL] [Abstract][Full Text] [Related]
15. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
[TBL] [Abstract][Full Text] [Related]
16. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
17. Triple reuptake inhibitors: Design, synthesis and structure-activity relationship of benzylpiperidine-tetrazoles.
Paudel S; Min X; Acharya S; Khadka DB; Yoon G; Kim KM; Cheon SH
Bioorg Med Chem; 2017 Oct; 25(20):5278-5289. PubMed ID: 28807575
[TBL] [Abstract][Full Text] [Related]
18. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
Fuller RW; Hemrick-Luecke SK; Snoddy HD
J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
[TBL] [Abstract][Full Text] [Related]
19. Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.
Shao L; Hewitt MC; Wang F; Malcolm SC; Ma J; Campbell JE; Campbell UC; Engel SR; Spicer NA; Hardy LW; Schreiber R; Spear KL; Varney MA
Bioorg Med Chem Lett; 2011 Mar; 21(5):1434-7. PubMed ID: 21310612
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, antiulcer and antidepressive activity of 4-(4-halophenyl)-2-phenyl-1,2,3,4-tetrahydroisoquinolines.
Mondeshka DM; Angelova IG; Tancheva CN; Ivanov CB; Daleva LD; Ivanova NS
Farmaco; 1994; 49(7-8):475-80. PubMed ID: 7945712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
